Rheumatoid Arthritis Flashcards

1
Q

NSAIDs
- Effect

A

Anti-inflammatory Action
- Decrease Prostaglandin E2
- Prostacyclin reduces vasodilation
- Reduction of mediators, number of inflammatory cells are not reduced

Analgesic Effect
- Decrease Prostaglandin generation
–> Less inflammatory mediators to activate nociceptive nerve ending
- Decreased Prostaglandin mediated vasodilation
–> Headache relief

Antipyretic Effect
- Prevent interleukin-1 from releasing prostaglandins in the CNS
–> Prevent elevation of hypothalamic set point for temperature control
–> Prevent fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NSAIDs
- MOA

A

Inhibit Cyclooxygenase Enzyme (COX-1/COX2)
- Inhibiting conversion of arachidonic acid to prostaglandin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NSAIDs
- COX-1 vs COX-2

A

COX-1: Constitutive Enzyme
- Protective role
–> Responsible for producing cytoprotective mucus in stomach
–> Responsible for platelet aggregation

COX-1: Inducible Enzyme
- Have to be stimulated by inflammatory mediators
–> Associated with inflammation
(COX-2 has no effect on stomach)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NSAIDs
- Indication

A
  • Pain
  • Inflammation
    -Fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

NSAIDs
- Adverse Effects

A

Contraindicated with Active Peptic Ulcer
Aspirin must be taken with food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

NSAIDs
- Nonselective Adverse Effects

A

Gastrointestinal Effects
- Inhibition of COX-1 affects production of cytoprotective mucus)

Edema
- PG inhibits Water and Salt retention

Acute Renal Failure
- Renal PGs protect high-risk patients by countering the effect of angiotensin 2 and vasopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NSAIDs
- COX-2 Adverse Effects

A

Cardiovascular
- Caused by the disruption in the balance between platelet-activating effects of COX-1 and platelet inhibiting effects of COX-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

NSAIDs
- All Adverse Effects

A

CNS (Confusion, Dizziness, Depression, Hallucination)
- Likely caused by COX-2 which is abundant in the CNS
- Could also be caused by COX-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Methotrexate
- Indication

A

Rheumatoid Arthritis
- Anti-inflammatory Action in small doses

Cancer
- Cytotoxic in large doses

Psoriasis Arthritis

Ankylosing Spndylitis

Polymyositis and Vaculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Methotrexate
- MOA

A

Disease-Modifying Antirheumatoid Drug (DMARD)

Folate Antagonist (Oral)
- Interferes with thymidylate synthesis (Essential in DNA synthesis)
–> Suppresses immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Methotrexate
- Adverse Effects

A

Gastrointestinal Disturbance

Dose-related Liver Toxicity

Bone Marrow Depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sulfasalazine
- Indication

A
  • Rheumatoid Arthritis
  • Juvenile Arthritis
  • Inflammatory Bowel Disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sulfasalazine
- MOA

A

Disease-Modifying Antirheumatoid Drug (DMARD)
- Acts in the colon to release salicylic acid
–> Anti-inflammatory action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Leflunomide
- Indication

A

Rheumatoid Arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Leflunomide
- MOA

A

Disease-Modifying Antirheumatoid Drug (DMARD) - (Oral)
- Increases amount of metabolite that inhibits dihydroorotate dehydrogenase
–> Inhibition of T-Cell Proliferation
–> Decreased production of autoantibodies by B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Leflunomide
- Adverse Effects

A
  • 25% of patients get diarrhoea
  • Increased BP
  • Weight Gain
17
Q

Targeted Synthetic DMARD
- MOA

A

Tofacitinib
- Inhibits Janus Kinase (JAK)
–> Reduces inflammation

18
Q

Biological DMARD
- MOA

A

Infliximab (IV)
- Monoclonal antibody against TNF-alpha that prevents it from interacting with receptors on inflammatory cells

19
Q

Biological DMARD
- Indication

A

Active Rheumatoid Arthritis
- Combined with methotrexate if DMARDs have yet to work

Ankylosing Spondylitis (If other therapy has not worked)

Psoriatic Arthritis (If other therapy has not worked)

20
Q

Biological DMARd
- Adverse Effects

A
  • Nausea
  • Vomiting
  • Headache
  • Upper Respiratory Tract Infections with Cough
21
Q

Colchicine
- MOA

A

Crystal Associated Arthritis (Gout)
- Inhibits microtubule polymerization
–> Binds protein and tubulin needed for mitosis

  • Inhibits Neutrophil
    –> Prevents activation and migration
  • Blocks inflammasome complex in neutrophils and monocyte
    –> Prevent inflammation
  • Inhibits superoxide anion production in response to Urate Crystals
  • Interrupts mast cell degranulation

Result: Inhibits Inflammation

22
Q

Colchicine
- Indications

A
  • Gout
  • Acute Attack (Joint pain caused by gout)
  • Prevent recurrent attacks (Uric Acid Lowering Therapy)
23
Q

Colchicine
- Adverse Effects

A

Contraindicated in Renal Failure
- Increased Risk of Toxicity

Narrow Therapeutic Index

Gastrointestinal
- Diarrhea (Very Common)

Bone Marrow Suppression
- Antimitotic target rapidly dividing cells such as bone marrow

Myopathy may occur
Neuropathy may occur

24
Q

Uricosurics
- MOA

A

Treats Gout
- Enhance Uric acid excretion
- Prevent Uric acid reabsorption (Probenecid)
–> Lower Uric Acid level

25
Q

Uricosurics
- Indications

A

Gout

26
Q

Uricosurics
- Adverse Effects

A

Do not give with Salicylates (Sulfasalazine)
- They will inhibit each other

Contraindicated in:
- Renal Insufficiency
- Urolithiases (Renal Stone)
- Peptic Ulcer

Mild Gastrointestinal Irritation

Mild Allergies (Rate)

27
Q

Xanthine Oxidase Inhibitors
- MOA

A

Allopurinol
- Purine Analogue of Hypoxanthine
- Inhibits Enzyme Xanthine Oxidase
–> Can not convert Hypoxanthine to Xanthine to Uric Acid

Febuxostat
- Nonpurine Inhibitor of Xanthine Oxidase
- Does not inhibit purine / pyrimidine synthesis

Result: Reduces production of Uric Acid

28
Q

Xanthine Oxidase Inhibitors
- Indications

A

Gout

Renal Stones made up of Uric Acid

Complicated Hyperuricemia

29
Q

Xanthine Oxidase Inhibitors
- Considerations

A

Contraindicated in those Hypersensitive to allopurinol

Allopurinol increases half-life of probenecid
- Enhances its Uricosuric effect

30
Q

Allopurinol
- Adverse Effect

A

Skin Reactions
- Mild to Severe

Stevens-Johnson Syndrome
- Toxic Epidermal Necrolysis (Rare & Fatal)

Liver Reactions
- Elevated liver enzymes, fever, eosinophilia, rash

Renal Insufficiency

Be careful of hypersensitivity to allopurinol

31
Q

Febuxostat
- Adverse Effect

A

No hypersensitivity

Cardiovascular
- Increased risk of myocardial infarction, stroke, cardiovascular death